| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 09/30/2004 | WO2004082707A2 Stabilisation of growth hormones in solution |
| 09/30/2004 | WO2004082676A1 Drug formulations having long and medium chain triglycerides |
| 09/30/2004 | WO2004082673A1 Liquid ophthalmic composition |
| 09/30/2004 | WO2004082670A1 Methadone-containing compositions for parenteral administration and use thereof |
| 09/30/2004 | WO2004082657A1 Sustained-release hydrogel preparation |
| 09/30/2004 | WO2004082640A2 Human serum albumin conjugates with therapeutic compounds |
| 09/30/2004 | WO2004082627A2 ENZYME REPLACEMENT THERAPY WITH 17-β-HYDROXYSTEROID DEHYDROGENASE-TYPE 2 |
| 09/30/2004 | WO2004082625A2 Self-emulsifying compositions, methods of use and preparation |
| 09/30/2004 | WO2004082620A2 Oxycodone conjugates with lower the abuse potential and extended duration of action |
| 09/30/2004 | WO2004082607A2 A method of preparing gas-filled polymer matrix microparticles useful for delivering drug |
| 09/30/2004 | WO2004082594A2 Alginate sponge and preparation method thereof |
| 09/30/2004 | WO2004082590A2 A low dose corticosteroid composition |
| 09/30/2004 | WO2004082589A2 Nasally administrable, bioavailable pharmaceutical composition of loratadine |
| 09/30/2004 | WO2004082588A2 Dispersible formulation of an anti-inflammatory agent |
| 09/30/2004 | WO2004082585A2 Water-soluble conjugates of phenytoin |
| 09/30/2004 | WO2004082580A2 Photostabilized topical formulations of ketoprofen containing two uv filters |
| 09/30/2004 | WO2004082576A2 Direct compressible trehalose solids |
| 09/30/2004 | WO2004082564A2 Coated enzyme granules |
| 09/30/2004 | WO2004082557A2 Package for and formulation of medicaments |
| 09/30/2004 | WO2004082378A1 Method of inhibiting freeze concentrating of substance in wet material, method of inhibiting deactivation of physiologically active substance, and process for producing lyophilizate or frozen matter having component homogeneously diffused therein |
| 09/30/2004 | WO2004060405A8 Tissue reactive compounds and compositions and uses thereof |
| 09/30/2004 | WO2004060315A3 Stable topical drug delivery compositions |
| 09/30/2004 | WO2004058143A3 High specificity anticancer pharmacological drug system, drug synthesis, and drug development process |
| 09/30/2004 | WO2004047790A3 Self-forming phospholipidic gels |
| 09/30/2004 | WO2004043400A3 Peptide deformylase activated prodrugs |
| 09/30/2004 | WO2004043331A3 Dermastick thickened ointment |
| 09/30/2004 | WO2004041869A8 Reactive polymers having chemoenzymatically hydrolysable functional groups |
| 09/30/2004 | WO2004032849A3 Methods of administering fgf18 |
| 09/30/2004 | WO2004030661A3 Therapeutic compositions comprising a boron-containing compound |
| 09/30/2004 | WO2004016214A3 Methods and compositions for treatment of macular and retinal disease |
| 09/30/2004 | WO2004000235A3 Breath freshening and oral cleansing product with magnolia bark extract |
| 09/30/2004 | WO2003102014A3 Compositions methods and systems for pulmonary delivery of recombinant human interferon alpha-2b |
| 09/30/2004 | WO2003072535A8 Substituted hydroxyethylamines |
| 09/30/2004 | WO2003026623A8 Intraorally disintegrating valdecoxib compositions |
| 09/30/2004 | WO2003024396A3 Dry powder medicament formulations |
| 09/30/2004 | US20040192900 Calicheamicin derivative-carrier conjugates |
| 09/30/2004 | US20040192776 Cationic lipid compositions targeting angiogenic endothelial cells |
| 09/30/2004 | US20040192769 Complexing with active materials; drug delivery; using modified polyoxyethylene glycol |
| 09/30/2004 | US20040192768 Aqueous solution of ascorbic acid and method for producing same |
| 09/30/2004 | US20040192661 Micronized eplerenone compositions |
| 09/30/2004 | US20040192647 topically applying an aqueous ophthalmic composition comprising N-acetylcarnosine, a N-acetylcarnosine derivative and a cellulose compound which increases intraocular absorption of N-acetylcarnosine; a hydrophilic hydrogel contact lens and an ocular polymer insert for topical application |
| 09/30/2004 | US20040192644 DDS compound and method for measurement thereof |
| 09/30/2004 | US20040192638 Method and composition for prolonging the residence time of drugs in the gut |
| 09/30/2004 | US20040192632 comprised of a VEGF Nucleic Acid Ligand and a Non-Immunogenic, High Molecular Weight Compound or Lipophilic Compound by identifying a VEGF Nucleic Acid Ligand by SELEX methodology and associating the VEGF Nucleic Acid Ligand with the Non-Immunogenic or High Molecular Weight Compound |
| 09/30/2004 | US20040192626 siNA molecule comprising a double-stranded structure that down-regulates expression of a target nucleic acid, wherein said siNA molecule does not require a 2'-hydroxyl group containing ribonucleotide; treating viral diseases such as SARS (severe acute respiratory syndrome virus), herpes, hepatitis, HIV |
| 09/30/2004 | US20040192622 intimate admixture of azithromycin and a stabilizing amount of an antioxidant; treating a bacterial infection |
| 09/30/2004 | US20040192600 Use of a specific COX-2 inhibitor, and/or a pharmaceutically acceptable salt and lung surfactant (SP-B and SP-C) for the production of medicaments for the treatment and/or prophylaxis of infant respiratory distress syndrome and adult respiratory distress syndrome |
| 09/30/2004 | US20040192597 Nucleic acids and corresponding proteins entitled 202P5A5 useful in treatment and detection of cancer |
| 09/30/2004 | US20040192589 Production of high molecular mass lectins |
| 09/30/2004 | US20040192585 Administering to a patient an amount of IRM(immune respose modifier) compound effective for treating basal cell carcinoma in a treatment cycle that includes at least two consecutive days in which the IRM compound is administered and at least one day in which the IRM compound is not administered |
| 09/30/2004 | US20040192578 High specificity anticancer drug design process |
| 09/30/2004 | US20040191926 Ptp1b inhibitors and ligands |
| 09/30/2004 | US20040191909 Glycerol viral suspension absent of divalent metal cations or alkali metal cations and capable for presevation and storage of adenovirus particles |
| 09/30/2004 | US20040191893 Implantable drug delivery system comprised of sealed thermoplastic polymer in association with permeable membrane; gene therapy; toxicity testing |
| 09/30/2004 | US20040191843 Cytotoxic mixture comprising polypeptides for treatment and prevention of cell proliferfative disorders |
| 09/30/2004 | US20040191834 Novel method |
| 09/30/2004 | US20040191329 Antimicrobial, atomically disordered, nanocrystalline silver components; greater penetration, coverage, efficacy |
| 09/30/2004 | US20040191326 Taste-masking vehicle for coated oxazolidinone particles |
| 09/30/2004 | US20040191321 Fabricating three dimensional nonspherical shapes using differential volume shrinkage; producing materials for advanced drug delivery and cell encapsulation; simple, low cost |
| 09/30/2004 | US20040191320 Pulmonary formulation |
| 09/30/2004 | US20040191318 Polymeric material having ligands capable of binding carbohydrates, proteins, lipids and/or peptide; preventing absorption; weight loss |
| 09/30/2004 | US20040191316 Washable, water resistant adhesive; crosslinked copolymer from such as acrylamide, diethyleneglycol methacrylate, n,n-methylenebisacrylamide, hexaglycerin and polyethyleneglycol; reusable bioelectrodes |
| 09/30/2004 | US20040191306 composition that includes a charged lipid for interaction with a charged therapeutic agent, yet which bears minimal external surface charge after formation. |
| 09/30/2004 | US20040191303 Inhibiting adhesion of cells to activated vascular endothelium from bloodstream; proteins and glycoproteins isolated from human or animal amniotic fluid, serum or urine |
| 09/30/2004 | US20040191297 Carotenoid formulation |
| 09/30/2004 | US20040191284 Self-emulsifying compositions, methods of use and preparation |
| 09/30/2004 | US20040191281 Carrier matrix having open pores or capillary spaces serving as liquid reservoir; does not require uniform distribution |
| 09/30/2004 | US20040191277 Dehydrated hydrogel precursor-based, tissue adherent compositions and methods of use |
| 09/30/2004 | US20040191276 Compositions and kits for compounding pharmaceuticals |
| 09/30/2004 | US20040191274 Topical composition |
| 09/30/2004 | US20040191261 Genetically engineered fusion protein comprising fibrin/fibrinogen binding moiety such as endothelial growth factor (VEGF165) C-terminal domain fused to a wound healing agent such as leptin |
| 09/30/2004 | US20040191247 Use of il-18 inhibitors for treating or preventing cns injuries |
| 09/30/2004 | US20040191243 Solid may comprise excipient of mannitol, polysorbate, succinate, citrate, Tris, phosphate, trehalose, amino acids, polyoxyethylene glyclol, albumins, sucrose, lactose, maltose, and/or sorbitol; kits; monoclonal antibodies; freeze drying |
| 09/30/2004 | US20040191234 Administering prebiotic such as fructo-oligosaccharide; measles prevention; vaccines; nutrients |
| 09/30/2004 | US20040191225 Injecting isolated cell through needle into organ, tissue, or tumor; drug delivery; carrier aids in retention of cells at injection site, or a tissue sealant or film to seal; tissue engineering; gene therapy |
| 09/30/2004 | US20040191219 HSA-free formulations of interferon-beta |
| 09/30/2004 | US20040191218 Pharmaceutical compositions and methods for treating cancer |
| 09/30/2004 | US20040191217 Orally administering interferon-tau to intestinal tract to produce measureable increase in patient's blood level of 2*,5*-oligoadenylate synthetase (OAS); autoimmune disease, viral infection and cancer treatment |
| 09/30/2004 | US20040191212 Phosphate-binding polymers for oral administration |
| 09/30/2004 | US20040191211 Tissue-specific transporter inhibitor |
| 09/30/2004 | US20040191207 Alpha-hydroxy acid ester drug delivery compositions and methods of use |
| 09/30/2004 | US20040191198 Pigment mixture, and the use thereof in cosmetics and in the foods and pharmaceuticals sector |
| 09/30/2004 | US20040191185 Ephedrine or fenfluramine; aluminum foil coated with a thin layer of drug is heated to form vapor; which condenses to form aerosol; rapid peak plasma concentration |
| 09/30/2004 | US20040191184 Delivery of muscle relaxants through an inhalation route |
| 09/30/2004 | US20040191183 Delivery of antiemetics through an inhalation route |
| 09/30/2004 | US20040191182 Delivery of analgesics through an inhalation route |
| 09/30/2004 | US20040191181 Vaporization of diphenhydramine from solid for breathing administerig |
| 09/30/2004 | US20040191180 Breathing analgesics after vaporization for administering pain killer for headaches |
| 09/30/2004 | US20040191179 Breathing antidepressants from aerosols for administering bupropion by heating on a solid support |
| 09/30/2004 | US20040191177 Solutions with glycerol or sorbitol and adjuvants with active material |
| 09/30/2004 | US20040191175 Radio-Opaque polymer biomaterials |
| 09/30/2004 | US20040191044 Systems, methods and apparatuses for manufacturing dosage forms |
| 09/30/2004 | DE19911058B4 Verwendung von nanoskaligen wasserlöslichen β-(1,3)-Glucanen The use of nanoscale water-soluble β- (1,3) glucans |
| 09/30/2004 | DE10312346A1 Kontrolliertes Freisetzungssystem Controlled release system |
| 09/30/2004 | DE10260882A1 Dosieraerosole mit Lecithin als oberflächenaktiver Substanz MDIs containing lecithin as surfactant |
| 09/30/2004 | DE10211801B4 Kosmetische und pharmazeutische Zubereitungen enthaltend einen oxalkylierten Polyglycerinester Cosmetic and pharmaceutical preparations containing one alkoxylated polyglycerol |
| 09/30/2004 | CA2633287A1 Combinations of rapamycin or its derivatives and pimecrolimus for the treatment of inflammation- and immunologically-mediated diseases |
| 09/30/2004 | CA2519589A1 Dispersible pharmaceutical composition for treatment of mastitis and otic disorders |
| 09/30/2004 | CA2519511A1 Mutant cholera holotoxin as an adjuvant and an antigen carrier protein |
| 09/30/2004 | CA2519300A1 Self-emulsifying compositions, methods of use and preparation |